JBT Marel (JBTM) news
Recent news
First Tracks Biotherapeutics shares rise 13.3% premarket after positive results from celiac disease drug trial
First Tracks Biotherapeutics Inc. (NASDAQ: FTBT) reported a 13.3% increase in premarket trading on October 12, 2026, following the release of positive clinical trial results . The company announced that the drug demonstrated a favorable safety profile and showed measurable efficacy in reducing…
AInvest Wire · 2d agoTata Power Renewables 121.2 mwh of storage projects in 2Q
Tata Power Renewable Energy Limited (TPREL) has made notable progress in the battery energy storage system (BESS) segment, with its 121.2 MWh of storage projects reported in the second quarter of the fiscal year. This development aligns with the company's broader strategy to expand its renewable…
AInvest Wire · 3d agoJBT Marel Corporation: Barclays initiates coverage with overweight rating and target price $150
AInvest Wire · Sep 8, 2026JBT Marel sees FY adj. EPS $7.85-$8.35, saw $8-$8.50
AInvest Wire · Aug 3, 2026JBT Marel 2Q adj EPS cont ops $1.95, est. $2.02
AInvest Wire · Aug 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.